Medical giant Merck & Co enters licensing agreement with BioImage  

2004.09.15
Merck & Co has signed a licensing agreement with the Danish biotech company that gives Merck & Co the rights to use BioImage's Redistribution technology

Medical giant Merck & Co has signed a licensing agreement with the Danish biotech company BioImage that gives Merck & Co the rights to use BioImage's Redistribution technology for drug discovery research. The financial terms have not been disclosed. Redistribution technology comprises a broad range of methods aimed at studying intracellular signalling events.

 

BioImage is a drug discovery company based in Copenhagen. It was created as a spin-out company from Novo Nordisk in 1999 and is owned by Apax Partners, Novo and Abingworth Management. BioImage is collaborating with companies such as Bristol-Meyers Squibb, Lilly and Amersham Biosciences. The news is reported by national newspaper Berlingske Tidende online and on BioImage's website.

 

Link > BioImage 

Next step

Explore business cases

Please contact me

Name
Company
E-mail
Phone
How can we help you?

IDK
We use cookies to make the website perform optimally. You accept cookies by closing the box or continuing to use the website. Click here to read more about cookies. ×